Capricor Therapeutics Inc (CAPR)

NASDAQ HEALTHCARE

$29.96 +2.92% RSI 43 Neutral Add Alert

Moving Averages

SMA 200

$18.73

Price above

Company Profile

Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$1.75B

P/E Ratio

None

EPS

$-2.18

Beta

0.484